A multicenter study highlights the oil's monounsaturated fat stores.
A heart-healthy diet in combination with canola oil may benefit weight loss, according to a study out of Canada. The human trial was presented at an American Heart Association event in March.
University researchers assigned 121 adults at risk for metabolic syndrome to a heart-healthy diet and one of five oils (canola oil, high-oleic canola oil, DHA-enriched canola oil, flax/safflower oil, or corn/safflower oil) in a smoothie eaten daily. After four weeks, subjects in the non-enriched canola and high-oleic canola groups experienced average 1.6% reductions in abdominal fat. The other oils provided no apparent weight loss, and they all happened to be low in monounsaturated fat. Canola oil, on the other hand, is high in this type of fat. More research is warranted for understanding this fat’s potential role in weight loss and as a practical tool for the food products industry.
Limiting the study to just five oil blends makes it difficult to see the full picture, but Angela Dansby of the Canola Council of Canada (a sponsor) says oils were carefully chosen to reflect best approaches to replacing saturated fats with healthier ones. Because flax oil runs with a high risk of rancidity, it was combined with safflower oil. Corn paired with safflower because its high plant sterol content might have otherwise influenced the study results.
The Government of Canada, the Canola Council of Canada (Winnipeg, MB, Canada), and Dow AgroSciences (Indianapolis) funded this study, dubbed the Canola Oil Multicenter Intervention Trial (COMIT).
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.